Skip to content
Home/Companies/MedTech/Graftys

Graftys

MedTech·France·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns Graftys?

Graftys is a French MedTech company, now owned by Noraker, which acquired it in 2024 from Go Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Go Capital
Investor
Go Capital
LVI2 · 2023

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
Noraker
Exit Year
2024

More from LVI2

Other portfolio companies in the same fund.

Lifeaz
Lifeaz
Active
HealthTechFrance· 2026
Olenbee
Active
France· 2026
Oxxius
Oxxius
Active
SoftwareFrance· 2026
Reelevant
Active
AdTechFrance· 2025
Addidream
Active
MedTechFrance· 2024
MoEa
MoEa
Active
ConsumerFrance· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Graftys?

Graftys is now owned by Noraker, which acquired it in 2024 from Go Capital.

When did Noraker acquire Graftys?

Noraker acquired Graftys in 2024, buying from Go Capital.

Who did Graftys sell to?

Go Capital sold Graftys to Noraker in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue